India's cosmetic treatment boom, reaching 1.29 million procedures in 2024, raises safety concerns. Experts are urging for stricter regulati...

Established beauty brands faced a sales growth slowdown in FY24, while new-age and global labels surged. Consumers preferred brands offerin...

Amwill Health Care's shares debuted at a 20% discount, opening at Rs 88.85 on the BSE SME platform against an issue price of Rs 111. The IP...

Amwill Healthcare’s SME IPO was fully subscribed 1.68 times by the final bidding day. The retail portion saw 2.41x demand, while QIBs subsc...

Amwill Healthcare’s SME IPO, which opened on February 6, was fully subscribed by February 7, with retail, non-institutional, and QIB segmen...

Amwill Healthcare's IPO launched with an overall subscription reaching 21% on the first day. The IPO includes fresh equity worth Rs 49 cror...

Following the discontinuation of Ayuga, Honasa Consumer will have six brands in its portfolio – Mamaearth, its largest brand, The Derma Co,...

CosmoGenesis boasts of extensive expertise in various facets of cosmetics, coupled with rich experience in natural & organic formulations, ...

Honasa Consumer, which owns and operates Mamaearth, on Thursday, reported a net profit of Rs 30.4 crore for the quarter ended March 2024. T...

Industry data shows emollients, protectives, have grown from Rs 1,390 crore MAT value in April 2022 to Rs 1,892 crore in April 2024. Likewi...

Honasa Consumer's The Derma Co achieved Rs 500 crore ARR, competing with Minimalist and Plum. Profitable in FY24 Q1-3, it surpassed Rs 350 ...

Honasa Consumer diversifies into colour cosmetics with Staze, targeting young consumers with affordable products. The company's strategic e...

Founded in 2018 by orthodontists, Arpi Mehta Shah, Pravin Shetty, Manjul Jain and Anirudh Kal, MakeO is a digital-first clinical cosmetic m...

“India is a focus market for us. We aspire to break into the top 5 in India," said M.V. Ramana, CEO – Branded Markets (India & Emerging Mar...

"At the end of the inspection, Aurolife has been issued a 'Form 483' with 1 observation and the observation is procedural in nature and the...

According to the most recent data compiled by research firm IMS, prescription sunblock sales increased by over 55 percent in May over 2020.

The round also saw participation from some existing investors like Belgian Sofina Ventures SA and some new funds such as UAE-based Evolvenc...